<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/differentiation-between-luminal-a-and-luminal-b-breast-cancer-using-intravoxel-incoherent-motion-and/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/differentiation-between-luminal-a-and-luminal-b-breast-cancer-using-intravoxel-incoherent-motion-and/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2017-11-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2017-11-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/differentiation-between-luminal-a-and-luminal-b-breast-cancer-using-intravoxel-incoherent-motion-and/"},"url":"https://clinicaltree.github.io/posts/differentiation-between-luminal-a-and-luminal-b-breast-cancer-using-intravoxel-incoherent-motion-and/"}</script><title>Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1512061200" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Nov 30, 2017 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Hiroko Kawashima MD</a> </em>, <em> <a href="">Tosiaki Miyati PhD</a> </em>, <em> <a href="">Naoki Ohno PhD</a> </em>, <em> <a href="">Masako Ohno MS</a> </em>, <em> <a href="">Masafumi Inokuchi MD</a> </em>, <em> <a href="">Hiroko Ikeda MD</a> </em>, <em> <a href="">Toshifumi Gabata MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2345 words"> <em>13 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The study aimed to investigate whether intravoxel incoherent motion (IVIM) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) can differentiate luminal-B from luminal-A breast cancer</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Biexponential analyses of IVIM and DCE MRI were performed using a 3.0-T MRI scanner, involving 134 patients with 137 pathologically confirmed luminal-type invasive breast cancers. Luminal-type breast cancer was categorized as luminal-B breast cancer (LBBC, Ki-67 ≧ 14%) or luminal-A breast cancer (LABC, Ki-67 &lt; 14%). Quantitative parameters from IVIM (pure diffusion coefficient [D], perfusion-related diffusion coefficient [D*], and fraction [f]) and DCE MRI (initial percentage of enhancement and signal enhancement ratio [SER]) were calculated. The apparent diffusion coefficient (ADC) was also calculated using monoexponential fitting. We correlated these data with the Ki-67 status.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The D and ADC values of LBBC were significantly lower than those of LABC ( <em>P</em> = 0.028, <em>P</em> = 0.037). The SER of LBBC was significantly higher than that of LABC ( <em>P</em> = 0.004). A univariate analysis showed that a significantly lower D (&lt;0.847 x 10 −3 mm 2 /s), lower ADC (&lt;0.960 × 10 −3 mm 2 /s), and higher SER (&gt;1.071) values were associated with LBBC (all <em>P</em> values &lt;0.01), compared to LABC. In a multivariate analysis, a higher SER (&gt;1.071; odds ratio: 3.0099, 95% confidence interval: 1.4246–6.3593; <em>P</em> = 0.003) value and a lower D (&lt;0.847 × 10 −3 mm 2 /s; odds ratio: 2.6878, 95% confidence interval: 1.0445–6.9162; <em>P</em> = 0.040) value were significantly associated with LBBC, compared to LABC.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The SER derived from DCE MRI and the D derived from IVIM are associated independently with the Ki-67 status in patients with luminal-type breast cancer.</p><h2 id="introduction"><span class="mr-2">Introduction</span><a href="#introduction" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Breast cancer is a group of heterogeneous diseases with various degrees of differentiation and gene expression of the cancer cell . Breast cancer is classified by genetic analysis into several intrinsic subtypes . Clinically, the three major subtypes categorized according to immunohistochemical methods are as follows: estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-positive, and triple negative . The treatment strategy is anti-HER2 therapy for HER2-positive cancer and chemotherapy for triple negative cancer .</p><p>ER-positive and HER2-negative (luminal-type) breast cancer is the most frequent subtype. Clinically, the Ki-67 labeling index is used to categorize luminal-type breast cancer into luminal-A breast cancer (LABC, Ki-67 &lt; 14%) and luminal-B breast cancer (LBBC, Ki67 ≧ 14%) . However, this measurement is not standardized, and there are many problems with quality control. The numerical value is expected to be different by the pathologist diagnosing the tumor. Unlike HER2-positive and triple negative cancer, the treatment strategy for luminal-type cancer is determined by the treating physician alone. For the patients with luminal-type cancer, physicians are often hesitant regarding which case to administer chemotherapy in addition to endocrine therapy . Ability to judge the grade of the malignancy of the whole tumor before the surgery or neoadjuvant chemotherapy is of major benefit to the physicians.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="patients"><span class="mr-2">Patients</span><a href="#patients" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mr-imaging"><span class="mr-2">MR Imaging</span><a href="#mr-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="diffusion-data-analysis"><span class="mr-2">Diffusion Data Analysis</span><a href="#diffusion-data-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Sb/S0=exp(−bD) S</p><p>b</p><p>/</p><p>S</p><p>0</p><p>=</p><p>exp</p><p>(</p><p>−</p><p>bD</p><p>)</p><p>where D is the perfusion-independent diffusion coefficient. Subsequently, D was applied to the following equation (biexponential function). Thereafter, with the D fixed, perfusion-related diffusion coefficient (D*) and fraction (f) were derived using all the b-values:</p><p>Sb/S0=(1−f)exp(−bD)+fexp(−bD*) S</p><p>b</p><p>/</p><p>S</p><p>0</p><p>=</p><p>(</p><p>1</p><p>−</p><p>f</p><p>)</p><p>exp</p><p>(</p><p>−</p><p>bD</p><p>)</p><p>+</p><p>f</p><p>exp</p><p>(</p><p>−</p><p>bD</p><p>*</p><p>)</p><p>where S b is the signal intensity with diffusion gradient b and S 0 is the signal intensity without a diffusion gradient.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Sb/S0=exp(−b⋅ADC) S</p><p>b</p><p>/</p><p>S</p><p>0</p><p>=</p><p>exp</p><p>(</p><p>−</p><p>b</p><p>⋅</p><p>ADC</p><p>)</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="dce-mri-data-analysis"><span class="mr-2">DCE MRI Data Analysis</span><a href="#dce-mri-data-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>PE1min=(S1min−S0)/S0×100 PE</p><p>1</p><p>min</p><p>=</p><p>(</p><p>S</p><p>1</p><p>min</p><p>−</p><p>S</p><p>0</p><p>)</p><p>/</p><p>S</p><p>0</p><p>×</p><p>100</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>SER=(S1min−S0)/(S5min−S0) SER</p><p>=</p><p>(</p><p>S</p><p>1</p><p>min</p><p>−</p><p>S</p><p>0</p><p>)</p><p>/</p><p>(</p><p>S</p><p>5</p><p>min</p><p>−</p><p>S</p><p>0</p><p>)</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="immunohistochemical-analysis"><span class="mr-2">Immunohistochemical Analysis</span><a href="#immunohistochemical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>IVIM and DCE MRI Parameters and ADC Values in Luminal-Type Breast Cancer</p><p>Luminal-A Luminal-B_P_ D (×10 −3 mm 2 /s) 0.932 ± 0.260 0.838 ± 0.214 0.028 f (%) 9.695 ± 6.837 9.778 ± 5.799 0.941 D * (×10 −3 mm 2 /s) 18.567 ± 24.003 17.149 ± 22.382 0.728 ADC (×10 −3 mm 2 /s) 1.068 ± 0.272 0.974 ± 0.232 0.037 PE 1min 141.800 ± 61.123 145.576 ± 50.562 0.705 SER 0.949 ± 0.293 1.095 ± 0.283 0.004</p><p>ADC, apparent diffusion coefficient; D , perfusion-related diffusion coefficient; D, pure diffusion coefficient; DCE, dynamic contrast-enhanced; f, fraction; IVIM, intravoxel incoherent motion; MRI, magnetic resonance imaging; PE 1min , initial percentage of enhancement; SER, signal enhancement ratio.</p><p>Data are mean values ± standard deviations.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiationBetweenLuminalAandLuminalBBreastCancerUsingIntravoxelIncoherentMotionandDynamicContrastEnhancedMagneticResonanceImaging/0_1s20S1076633217303070.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiationBetweenLuminalAandLuminalBBreastCancerUsingIntravoxelIncoherentMotionandDynamicContrastEnhancedMagneticResonanceImaging/0_1s20S1076633217303070.jpg" alt="Figure 1, Box plots of pure diffusion coefficient (D) ( a ), fraction (f) ( b ), perfusion-related diffusion coefficient (D*) ( c ), and apparent diffusion coefficient (ADC) ( d ) in luminal-A breast cancer and luminal-B breast cancer. The top and bottom lines of the box represent the 25th–75th percentile values, and the line in the box represents the median value." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiationBetweenLuminalAandLuminalBBreastCancerUsingIntravoxelIncoherentMotionandDynamicContrastEnhancedMagneticResonanceImaging/1_1s20S1076633217303070.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiationBetweenLuminalAandLuminalBBreastCancerUsingIntravoxelIncoherentMotionandDynamicContrastEnhancedMagneticResonanceImaging/1_1s20S1076633217303070.jpg" alt="Figure 2, Box plots of initial percentage of enhancement (PE 1min ) ( a ) and signal enhancement ratio (SER) ( b ) in luminal-A breast cancer and luminal-B breast cancer. The top and bottom lines of the box represent the 25th–75th percentile values, and the line in the box represents the median value." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Logistic Regression Analysis of Factors Associated with Luminal-A Versus Luminal-B</p><p>Univariate Analysis Odds Ratio (95% CI)<em>P</em> Value Multivariate Analysis Odds Ratio (95% CI)<em>P</em> Value D 3.5648 (1.7406–7.3010) 0.0005 2.6878 (1.0445–6.9162) 0.0403 ADC 2.5846 (1.2762–5.2347) 0.0084 1.4727 (0.5663–3.8300) 0.4273 SER 3.0556 (1.5033–6.2108) 0.0020 3.0099 (1.4246–6.3593) 0.0039</p><p>ADC, apparent diffusion coefficient; CI, confidence interval; D, pure diffusion coefficient; SER, signal enhancement ratio.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiationBetweenLuminalAandLuminalBBreastCancerUsingIntravoxelIncoherentMotionandDynamicContrastEnhancedMagneticResonanceImaging/2_1s20S1076633217303070.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiationBetweenLuminalAandLuminalBBreastCancerUsingIntravoxelIncoherentMotionandDynamicContrastEnhancedMagneticResonanceImaging/2_1s20S1076633217303070.jpg" alt="Figure 3, A representative case of luminal-A breast cancer (a1–a3) compared with luminal-B breast cancer (b1–b3). Axial dynamic contrast-enhanced, fat-suppressed, T1-weighted images 1 minute (a1, b1) and 5 minutes (a2, b2) after administration of gadolinium and axial diffusion-weighted images (DWI) with a b-value of 800 s/mm 2 (a3, b3) are shown. ( a ) A 71-year-old woman with luminal-A breast cancer (Ki-67 labeling index = 3%). The PE 1min and SER values were 292.78 and 1.15. The pure diffusion coefficient (D), fraction (f), perfusion-related diffusion coefficient (D*), and apparent diffusion coefficient (ADC) values were 1.82 × 10 −3 mm 2s, 3.36 %, 3.00 × 10 −3 mm 2s, and 1.85 × 10 −3 mm 2s. ( b ) A 68-year-old woman with luminal-B breast cancer (Ki-67 labeling index = 38%). The PE 1min and SER values were 159.33 and 1.58. The D, f, D*, and ADC values were 0.89 × 10 −3 mm 2s, 10.99 %, 3.00 × 10 −3 mm 2s, and 1.02 × 10 −3 mm 2s." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Sorlie T., Perou C.M., Tibshirani R., et. al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: pp. 10869-10874.</p><li><p>2. Van de Vijver M.J., He Y.D., van’t Veer L.J., et. al.: A gene expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: pp. 1999-2009.</p><li><p>3. Desmedt C., Haibe-Kains B., Wirapati P., et. al.: Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res 2008; 14: pp. 5158-5165.</p><li><p>4. Rouzier R., Perou C.M., Symmans W.F., et. al.: Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005; 11: pp. 5678-5685.</p><li><p>5. Montagna E., Bagnardi V., Rotmensz N., et. al.: Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation. Breast Cancer Res Treat 2011; 129: pp. 867-875.</p><li><p>6. Cheang M.C., Chia S.K., Voduc D., et. al.: Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 2009; 101: pp. 736-750.</p><li><p>7. Sanchez-Munoz A., Garcia-Tapiador A.M., Martinez-Ortega E., et. al.: Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Clin Transl Oncol 2008; 10: pp. 646-653.</p><li><p>8. Goldhirsch A., Wood W.C., Coates A.S., et. al.: Strategies for subtypes: dealing with the diversity of breast cancer—highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer. Ann Oncol 2011; 22: pp. 1736-1747.</p><li><p>9. Goldhirsch A., Winer E.P., Coates A.S., et. al.: Personalizing the treatment of woman with early breast cancer—highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer. Ann Oncol 2013; 24: pp. 2206-2223.</p><li><p>10. Kontzoglou K., Palla V., Karaolanis G., et. al.: Correlation between Ki67 and breast cancer prognosis. Oncology 2013; 84: pp. 219-225.</p><li><p>11. Colleoni M., Viale G., Zahrieh D., et. al.: Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy. Ann Oncol 2008; 19: pp. 465-472.</p><li><p>12. Yerushalmi R., Woods R., Ravdin P.M., et. al.: Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol 2010; 11: pp. 174-183.</p><li><p>13. Dowsett M., Nielsen T.O., A’Hern R., et. al.: Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 2011; 103: pp. 1656-1664.</p><li><p>14. Guo Y., Cai Y.Q., Cai Z.L., et. al.: Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16: pp. 172-178.</p><li><p>15. Kim S.H., Cha E.S., Kim H.S., et. al.: Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging 2009; 30: pp. 615-620.</p><li><p>16. Martincich L., Deantoni V., Bertotto I., et. al.: Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol 2012; 22: pp. 1519-1528.</p><li><p>17. Youk J.H., Son E.J., Chung J., et. al.: Triple-negative breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes. Eur Radiol 2012; 22: pp. 1724-1734.</p><li><p>18. Park S.H., Choi H.Y., Hahn S.Y.: Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 tesla. J Magn Reson Imaging 2015; 41: pp. 175-182.</p><li><p>19. Mori N., Ota H., Mugikura S., et. al.: Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology 2014; 274: pp. 66-73.</p><li><p>20. Le Bihan D., Breton E., Lallemand D., et. al.: MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: pp. 401-407.</p><li><p>21. Tamura T., Usui S., Murakami S., et. al.: Biexponential signal attenuation analysis of diffusion-weighted imaging of breast. Magn Reson Med Sci 2010; 9: pp. 195-207.</p><li><p>22. Sigmund E.E., Cho G.Y., Kim S., et. al.: Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med 2011; 65: pp. 1437-1447.</p><li><p>23. Liu C., Liang C., Liu Z., et. al.: Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI. Eur J Radiol 2013; 82: pp. e782-e789.</p><li><p>24. Bokacheva L., Kaplan J.B., Giri D.D., et. al.: Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. J Magn Reson Imaging 2014; 40: pp. 813-823.</p><li><p>25. Liu C., Wang K., Chan Q., et. al.: Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging. Eur Radiol 2016; 26: pp. 3888-3898.</p><li><p>26. Ma D., Lu F., Zou X., et. al.: Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions. Magn Reson Imaging 2017; 36: pp. 175-179.</p><li><p>27. Lee Y.J., Kim S.H., Kang B.J., et. al.: Intravoxel incoherent motion (IVIM)-derived parameters in diffusion-weighted MRI: associations with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging 2017; 45: pp. 1394-1406.</p><li><p>28. Kim Y., Ko K., Kim D., et. al.: Intravoxel incoherent motion diffusion-weighted MR imaging of breast cancer: association with histopathological features and subtypes. Br J Radiol 2016; 89: pp. 20160140.</p><li><p>29. Cho G.Y., Moy L., Kim S.G., et. al.: Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors. Eur Radiol 2016; 26: pp. 2547-2558.</p><li><p>30. Patel J., Sigmund E.E., Rusinek H., et. al.: Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010; 31: pp. 589-600.</p><li><p>31. Ohno N., Miyati T., Kobayashi S., et. al.: Modified triexponential analysis of intravoxel incoherent motion for brain perfusion and diffusion. J Magn Reson Imaging 2016; 43: pp. 818-823.</p><li><p>32. Partridge S.C., Heumann E.J., Hylton N.M.: Semi-automated analysis for MRI of breast tumors. Stud Health Technol Inform 1999; 62: pp. 259-260.</p><li><p>33. Kato F., Kudo K., Yamashita H., et. al.: Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI. Eur J Radiol 2016; 85: pp. 96-102.</p><li><p>34. Shin J.K., Kim J.Y.: Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: associations between quantitative MR parameters and Ki-67 proliferation status. J Magn Reson Imaging 2016; 45: pp. 94-102.</p><li><p>35. Stomper P.C., Herman S., Klippenstein D.L., et. al.: Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197: pp. 387-395.</p><li><p>36. Fischer U., Kopka L., Brinck U., et. al.: Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. Eur Radiol 1997; 7: pp. 1002-1005.</p><li><p>37. Lee S., Cho N., Kim S., et. al.: Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol 2008; 9: pp. 10-18.</p><li><p>38. Koo H.R., Cho N., Song I.C., et. al.: Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers. J Magn Reson Imaging 2012; 36: pp. 145-151.</p><li><p>39. Kim J.Y., Kim S.H., Kim Y.J., et. al.: Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?. Magn Reson Imaging 2015; 33: pp. 72-80.</p><li><p>40. Lee H.S., Kim S.H., Kang B.J., et. al.: Perfusion parameters in dynamic contrast-enhanced MRI and apparent diffusion coefficient value in diffusion-weighted: association with prognostic factors in breast cancer. Acad Radiol 2016; 23: pp. 446-456.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-24/'>Volume 24</a>, <a href='/categories/issue-12/'>Issue 12</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Differentiation%20Between%20Luminal-A%20and%20Luminal-B%20Breast%20Cancer%20Using%20Intravoxel%20Incoherent%20Motion%20and%20Dynamic%20Contrast-Enhanced%20Magnetic%20Resonance%20Imaging%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdifferentiation-between-luminal-a-and-luminal-b-breast-cancer-using-intravoxel-incoherent-motion-and%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Differentiation%20Between%20Luminal-A%20and%20Luminal-B%20Breast%20Cancer%20Using%20Intravoxel%20Incoherent%20Motion%20and%20Dynamic%20Contrast-Enhanced%20Magnetic%20Resonance%20Imaging%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdifferentiation-between-luminal-a-and-luminal-b-breast-cancer-using-intravoxel-incoherent-motion-and%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdifferentiation-between-luminal-a-and-luminal-b-breast-cancer-using-intravoxel-incoherent-motion-and%2F&text=Differentiation%20Between%20Luminal-A%20and%20Luminal-B%20Breast%20Cancer%20Using%20Intravoxel%20Incoherent%20Motion%20and%20Dynamic%20Contrast-Enhanced%20Magnetic%20Resonance%20Imaging%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/3d-registration-of-mpmri-for-assessment-of-prostate-cancer-focal-therapy/"><div class="card-body"> <em class="small" data-ts="1512061200" data-df="ll" > Nov 30, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>3D Registration of mpMRI for Assessment of Prostate Cancer Focal Therapy</h3><div class="text-muted small"><p> Rationale and Objectives This study aimed to assess a novel method of three-dimensional (3D) co-registration of prostate magnetic resonance imaging (MRI) examinations performed before and after pr...</p></div></div></a></div><div class="card"> <a href="/posts/automated-volumetric-mammographic-breast-density-measurements-may-underestimate-percent-breast-densi/"><div class="card-body"> <em class="small" data-ts="1512061200" data-df="ll" > Nov 30, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automated Volumetric Mammographic Breast Density Measurements May Underestimate Percent Breast Density for High-density Breasts</h3><div class="text-muted small"><p> Rationale and Objectives The purpose of this study was to evaluate discrepancy in breast composition measurements obtained from mammograms using two commercially available software methods for sys...</p></div></div></a></div><div class="card"> <a href="/posts/ct-image-based-decision-support-system-for-categorization-of-liver-metastases-into-primary-cancer-si/"><div class="card-body"> <em class="small" data-ts="1512061200" data-df="ll" > Nov 30, 2017 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>CT Image-based Decision Support System for Categorization of Liver Metastases Into Primary Cancer Sites</h3><div class="text-muted small"><p> Rationale and Objectives This study aimed to provide decision support for the human expert, to categorize liver metastases into their primary cancer sites. Currently, once a liver metastasis is de...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/differential-aging-signals-in-abdominal-ct-scans/" class="btn btn-outline-primary" prompt="Older"><p>Differential Aging Signals in Abdominal CT Scans</p></a> <a href="/posts/differentiation-of-intrahepatic-cholangiocellular-carcinoma-from-hepatocellular-carcinoma-in-the-cir/" class="btn btn-outline-primary" prompt="Newer"><p>Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
